A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models
Background: Multiple sclerosis (MS) is an autoimmune disease characterised by the demyelination of mature oligodendrocytes in the central nervous system. Recently, several studies have indicated the vital roles of fatty acid-binding proteins (FABPs) 5 and 7 in regulating the immune response. Methods...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396421003753 |
id |
doaj-f03e650614f94a32a34a95fbc01c8a6c |
---|---|
record_format |
Article |
spelling |
doaj-f03e650614f94a32a34a95fbc01c8a6c2021-10-07T04:26:14ZengElsevierEBioMedicine2352-39642021-10-0172103582A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse modelsAn Cheng0Wenbin Jia1Ichiro Kawahata2Kohji Fukunaga3Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, JapanDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, JapanDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, JapanDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Corresponding author.Background: Multiple sclerosis (MS) is an autoimmune disease characterised by the demyelination of mature oligodendrocytes in the central nervous system. Recently, several studies have indicated the vital roles of fatty acid-binding proteins (FABPs) 5 and 7 in regulating the immune response. Methods: We assessed a novel FABP5/FABP7 inhibitor, FABP ligand 6 (MF 6), as a potential therapeutic for MS therapy. In vivo, we established MOG35-55-administered experimental autoimmune encephalomyelitis (EAE) mice as an MS mouse model, followed by prophylactic and symptomatic treatment with MF 6. The therapeutic effect of MF 6 was determined using behavioural and biochemical analyses. In vitro, MF 6 effects on astrocytes and oligodendrocytes were examined using both astrocyte primary culture and KG-1C cell lines. Findings: Prophylactic and symptomatic MF 6 therapy reduced myelin loss and clinical EAE symptoms. Furthermore, oxidative stress levels and GFAP-positive and ionised calcium-binding adaptor protein-1-positive cells were reduced in the spinal cord of MF 6-treated mice. In addition, MF 6 attenuated lipopolysaccharide-stimulated interleukin-1β and tumour necrosis factor-α accumulation in primary astrocyte culture. Moreover, MF 6 indicated a powerful protective function for the mitochondria in the oligodendrocytes of EAE mice via FABP5 inhibition. Interpretations: MF 6 is a potent inhibitor of FABP5 and FABP7; targeted inhibition of the two proteins may confer potential therapeutic effects in MS via immune inhibition and oligodendrocyte protection. Funding: This work was supported by the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development (JP17dm0107071, JP18dm0107071, JP19dm0107071, and JP20dm0107071).http://www.sciencedirect.com/science/article/pii/S2352396421003753Multiple sclerosisFatty acid-binding proteinsAstrocyteMicrogliaMitochondria |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
An Cheng Wenbin Jia Ichiro Kawahata Kohji Fukunaga |
spellingShingle |
An Cheng Wenbin Jia Ichiro Kawahata Kohji Fukunaga A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models EBioMedicine Multiple sclerosis Fatty acid-binding proteins Astrocyte Microglia Mitochondria |
author_facet |
An Cheng Wenbin Jia Ichiro Kawahata Kohji Fukunaga |
author_sort |
An Cheng |
title |
A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models |
title_short |
A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models |
title_full |
A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models |
title_fullStr |
A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models |
title_full_unstemmed |
A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models |
title_sort |
novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models |
publisher |
Elsevier |
series |
EBioMedicine |
issn |
2352-3964 |
publishDate |
2021-10-01 |
description |
Background: Multiple sclerosis (MS) is an autoimmune disease characterised by the demyelination of mature oligodendrocytes in the central nervous system. Recently, several studies have indicated the vital roles of fatty acid-binding proteins (FABPs) 5 and 7 in regulating the immune response. Methods: We assessed a novel FABP5/FABP7 inhibitor, FABP ligand 6 (MF 6), as a potential therapeutic for MS therapy. In vivo, we established MOG35-55-administered experimental autoimmune encephalomyelitis (EAE) mice as an MS mouse model, followed by prophylactic and symptomatic treatment with MF 6. The therapeutic effect of MF 6 was determined using behavioural and biochemical analyses. In vitro, MF 6 effects on astrocytes and oligodendrocytes were examined using both astrocyte primary culture and KG-1C cell lines. Findings: Prophylactic and symptomatic MF 6 therapy reduced myelin loss and clinical EAE symptoms. Furthermore, oxidative stress levels and GFAP-positive and ionised calcium-binding adaptor protein-1-positive cells were reduced in the spinal cord of MF 6-treated mice. In addition, MF 6 attenuated lipopolysaccharide-stimulated interleukin-1β and tumour necrosis factor-α accumulation in primary astrocyte culture. Moreover, MF 6 indicated a powerful protective function for the mitochondria in the oligodendrocytes of EAE mice via FABP5 inhibition. Interpretations: MF 6 is a potent inhibitor of FABP5 and FABP7; targeted inhibition of the two proteins may confer potential therapeutic effects in MS via immune inhibition and oligodendrocyte protection. Funding: This work was supported by the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development (JP17dm0107071, JP18dm0107071, JP19dm0107071, and JP20dm0107071). |
topic |
Multiple sclerosis Fatty acid-binding proteins Astrocyte Microglia Mitochondria |
url |
http://www.sciencedirect.com/science/article/pii/S2352396421003753 |
work_keys_str_mv |
AT ancheng anovelfattyacidbindingprotein5and7inhibitoramelioratesoligodendrocyteinjuryinmultiplesclerosismousemodels AT wenbinjia anovelfattyacidbindingprotein5and7inhibitoramelioratesoligodendrocyteinjuryinmultiplesclerosismousemodels AT ichirokawahata anovelfattyacidbindingprotein5and7inhibitoramelioratesoligodendrocyteinjuryinmultiplesclerosismousemodels AT kohjifukunaga anovelfattyacidbindingprotein5and7inhibitoramelioratesoligodendrocyteinjuryinmultiplesclerosismousemodels AT ancheng novelfattyacidbindingprotein5and7inhibitoramelioratesoligodendrocyteinjuryinmultiplesclerosismousemodels AT wenbinjia novelfattyacidbindingprotein5and7inhibitoramelioratesoligodendrocyteinjuryinmultiplesclerosismousemodels AT ichirokawahata novelfattyacidbindingprotein5and7inhibitoramelioratesoligodendrocyteinjuryinmultiplesclerosismousemodels AT kohjifukunaga novelfattyacidbindingprotein5and7inhibitoramelioratesoligodendrocyteinjuryinmultiplesclerosismousemodels |
_version_ |
1716839942591610880 |